relaxation phenotype
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| African American | associated_with | relaxation | 0.001 | 1 |
| alpha | biomarker_for | relaxation | — | 1 |
| cannabinoids | associated_with | relaxation | — | 1 |
| hyperpolarization | regulates | relaxation | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- Spatial organization of RYRs and BK channels underlying the activation of STOCs by Ca(2+) sparks in airway myocytes. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- Impact of maternal stress, depression and anxiety on fetal neurobehavioral development. (2009)
- EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
- Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking. (2008)
- Alcoholism and human electrophysiology. (2003)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| relaxation | phenotype | 8 | 11 |
| relaxed state | phenotype | 1 | 1 |
| relax | phenotype | — | — |
| relaxation during early experimentation | phenotype | — | — |